Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Total Non-Current Liabilities (2020 - 2026)

Oric Pharmaceuticals filings provide 7 years of Total Non-Current Liabilities readings, the most recent being $17.8 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 0.87% to $17.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.8 million through Mar 2026, up 0.87% year-over-year, with the annual reading at $20.4 million for FY2025, 17.83% down from the prior year.
  • Total Non-Current Liabilities hit $17.8 million in Q1 2026 for Oric Pharmaceuticals, down from $20.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $24.8 million in Q4 2024 and bottomed at $11.8 million in Q1 2022.
  • Average Total Non-Current Liabilities over 5 years is $17.4 million, with a median of $17.8 million recorded in 2026.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 53.95% in 2022 before it dropped 17.83% in 2025.
  • Oric Pharmaceuticals' Total Non-Current Liabilities stood at $15.4 million in 2022, then soared by 32.95% to $20.5 million in 2023, then grew by 21.45% to $24.8 million in 2024, then dropped by 17.83% to $20.4 million in 2025, then dropped by 12.96% to $17.8 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Total Non-Current Liabilities are $17.8 million (Q1 2026), $20.4 million (Q4 2025), and $20.2 million (Q3 2025).